May 22, 2023

Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit

New Kit Enables Automation of DNA Cloning on the BioXp® System Beginning from Linear DNA, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation SAN DIEGO, May 22, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first […]

Read More

Telstra Ventures-backed LambdaTest expands in the ANZ Region

LambdaTest provides an enterprise execution environment for organizations undergoing rapid digital transformation. Backed by Telstra Ventures, LambdaTest addresses the growing demand for secure and compliant test execution infrastructure within their private cloud. San Francisco, May 22, 2023 (GLOBE NEWSWIRE) — LambdaTest, a leading intelligent digital experience testing cloud, announced that its innovative solution for test execution […]

Read More

Webull Celebrates Fifth Anniversary with the Launch of Webull 9.0 and Smart Advisor

Leading mobile brokerage continues to innovate to meet the evolving needs of retail investors NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) — Webull, a leading commission-free trading platform, is proudly celebrating its five-year anniversary. Since May 2018, Webull has offered its users professional level tools and analytics while creating an enjoyable, user-friendly investing experience. To […]

Read More

Meltwater delivers the future of media, social and consumer intelligence through its industry-leading AI engine and ChatGPT integration

Meltwater expands on 20 years of robust AI capabilities with integration of OpenAI models and advanced algorithms to deliver insights, moving away from the time and guesswork needed to make sense of billions of pieces of online data. SAN FRANCISCO, May 22, 2023 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social and consumer […]

Read More

AiViva Biopharma Initiates Phase 1 Clinical Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema

Novel JEL™ Technology for Periocular Administration COSTA MESA, Calif., May 22, 2023 (GLOBE NEWSWIRE) — AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has begun a Phase 1 trial and completed dosing the first cohort of patients diagnosed with wet age-related macular degeneration (wAMD), and/or diabetic macular edema (DME). “We are very excited […]

Read More

Bombardier Challenger 3500 Business Jet Makes European Debut at EBACE 2023

Bombardier’s Challenger 3500 Business Jet The Challenger 3500 business jet, which will be on display at the European airshow, offers customers in the region a preview of Bombardier’s eco-design vision The Challenger 3500 aircraft boasts the first eco app* solution available in business aviation, optimizing flight plans for a reduced environmental footprint Passengers benefit from […]

Read More